Literature DB >> 3621119

Liposarcoma of the musculoskeletal system.

G G Orson, F H Sim, H M Reiman, W F Taylor.   

Abstract

Two hundred eleven cases with the diagnosis of liposarcoma of the musculoskeletal system were reviewed. The mean age at diagnosis was 52.9 years. The primary site was the proximal lower extremity in 52%. Myxoid-type liposarcoma was most frequent (60%). Metastasis was observed in 45%. One hundred two patients without prior treatment or distant spread at diagnosis were studied separately. Recurrence was noted in 26%. The median survival time was 7.5 years, with a 5-year survival of 59% and a 10-year survival of 45%. Significant variation in survival time was related to histologic grade, Enneking's stage, tumor size, and histologic type.

Entities:  

Mesh:

Year:  1987        PMID: 3621119     DOI: 10.1002/1097-0142(19870915)60:6<1362::aid-cncr2820600634>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Multifactorial analysis of survival in primary extremity liposarcoma.

Authors:  H R Chang; J Gaynor; C Tan; S I Hajdu; M F Brennan
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

2.  Prognostic significance of grading (MIB-1 system) in patients with myxoid liposarcoma.

Authors:  U Tateishi; T Hasegawa; Y Beppu; A Kawai; N Moriyama
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

Review 3.  Lipomatous tumours of soft tissues: an update.

Authors:  T Mentzel; C D Fletcher
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Metastatic patterns of myxoid/round cell liposarcoma: a review of a 25-year experience.

Authors:  Naofumi Asano; Michiro Susa; Seiichi Hosaka; Robert Nakayama; Eisuke Kobayashi; Katsuhito Takeuchi; Keisuke Horiuchi; Yoshihisa Suzuki; Ukei Anazawa; Makio Mukai; Yoshiaki Toyama; Hiroo Yabe; Hideo Morioka
Journal:  Sarcoma       Date:  2012-04-01

5.  Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy.

Authors:  Hyo Song Kim; Jeeyun Lee; Seong Yoon Yi; Hyun Jung Jun; Yoon-La Choi; Geung Hwan Ahn; Sung Wook Seo; Do Hoon Lim; Yong Chan Ahn; Joon Oh Park; Sung Joo Kim
Journal:  BMC Cancer       Date:  2009-06-26       Impact factor: 4.430

Review 6.  Management of myxoid liposarcoma of the extremity.

Authors:  Yehia Tfayli; Ahmad Baydoun; Ahmad Salaheddine Naja; Said Saghieh
Journal:  Oncol Lett       Date:  2021-06-09       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.